Italy reaffirms support of Gavi and CEPI with €5 million grant to IFFIm
Italy reaffirms support of Gavi and CEPI with €5 million grant to IFFIm
26 January 2021
Italy’s new grant will provide immediate funding for CEPI’s COVID-19 vaccine research and development programme.
- Italy’s new grant will provide immediate funding for CEPI’s COVID-19 vaccine research and development programme
- The funding adds to Italy’s €150 million pledge to IFFIm during the 2020 Global Vaccine Summit and brings its total IFFIm commitments to €654 million
- Italy is one of IFFIm’s founders and leading donors
London, 26 January 2021 - Italy has committed €5 million to the International Finance Facility for Immunisation (IFFIm) to provide expedited funding for the Coalition for Epidemic Preparedness Innovations (CEPI). The funding is part of Italy’s €10 million contribution to CEPI announced in May 2020 that will support CEPI’s work on research and development of vaccines against emerging infectious diseases, including its COVID-19 programme.
CEPI is an Oslo-based public private initiative that accelerates development of vaccines against emerging infectious diseases and enables equitable access to these vaccines during outbreaks. As part of the value chain of vaccine development and delivery, CEPI complements Gavi’s broader life-saving mission. With Gavi and the World Health Organisation (WHO), CEPI co-leads COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. CEPI also leads the COVAX vaccine research and development portfolio, investing across a variety of promising candidates.
This latest funding extends Italy’s commitment to immunisation and vaccine development. Italy announced at the June 2020 Global Vaccine Summit that it would provide €150 million to IFFIm, bringing its total IFFIm commitments to €654 million. In addition to its support through IFFIm, Italy pledged €100 million in direct funding to Gavi 5.0.
Italy is one of IFFIm’s initial donors and took a leading role in launching the first Advance Market Commitment to accelerate the development and availability of pneumococcal vaccines. It was the largest donor to the AMC with a pledge of US$ 635 million. Italy has currently committed more than US$ 100 million to the new Gavi COVAX AMC.
About IFFIm
IFFIm is an independent UK charity established in 2006 in support of Gavi as a way to accelerate funding for immunisation in the world’s poorest countries. IFFIm has been instrumental in accelerating Gavi’s impact and safeguarding financial flexibility. Since 2006, IFFIm has leveraged donor pledges to issue Vaccines Bonds on global capital markets, generating more than US$ 6.2 billion through 35 issuances in eight currencies. IFFIm is widely regarded as a pioneering social bond issuer, and Vaccines Bonds have enjoyed strong demand from socially responsible investors due to the clarity and focus of Gavi’s mission.
Media contacts
James Fulker, Media Manager
Mob: +41 79 429 55 05
Email: jfulker@gavi.org
Jeff Weintraub, Media Relations Consultant (U.S.)
Mob: +1-202-403-7695
Email: jweintraub@gavi.org
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024